Optimal beam arrangement for stereotactic body radiation therapy delivery in lung tumors

References

• Graham PH, Gebski VJ, Langlands AO. Radical radiotherapy for early nonsmall cell lung cancer. Int J Radiat Oncol Biol Phys. 1995; 31:261–6.
   PubMed Web of Science ®Google Scholar
• Qiao X, Tullgren O, Lax I, Sirzen F, Lewensohn R. The role of radiotherapy in treatment of stage I non-small cell lung cancer. Lung Cancer. 2003; 41:1–11.
   PubMed Web of Science ®Google Scholar
• Krol AD, Aussems P, Noordijk EM, Hermans J, Leer JW. Local irradiation alone for peripheral stage I lung cancer: Could we omit the elective regional nodal irradiation?. Int J Radiat Oncol Biol Phys. 1996; 34:297–302.
   PubMed Web of Science ®Google Scholar
• Haffty BG, Goldberg NB, Gerstley J, Fischer DB, Peschel RT. Results of radical radiation therapy in clinical stage I technically operable non-small cell lung cancer. Int J Radiat Oncol Biol Phys. 1988; 15:69–73.
   PubMed Web of Science ®Google Scholar
• Dosoretz DE, Katin MJ, Blitzer PH, Rubenstein JH, Salenius S, Rashid M, . Radiation therapy in the management of medically inoperable carcinoma of the lung: Results and implications for future treatment strategies. Int J Radiat Oncol Biol Phys. 1992; 24:3–9.
   PubMed Web of Science ®Google Scholar
• Nagata Y, Takayama K, Matsuo Y, Norihisa Y, Mizowaki T, Sakamoto T, . Clinical outcomes of a phase I/II study of 48 Gy of stereotactic body radiotherapy in 4 fractions for primary lung cancer using a stereotactic body frame. Int J Radiat Oncol Biol Phys. 2005; 63:1427–31.
   PubMed Web of Science ®Google Scholar
• McGarry RC, Papiez L, Williams M, Whitford T, Timmerman RD. Stereotactic body radiation therapy of early-stage non-small-cell lung carcinoma: Phase I study. Int J Radiat Oncol Biol Phys. 2005; 63:1010–5.
   PubMed Web of Science ®Google Scholar
• Timmerman R, Papiez L, MaGarry R, Likes L, DesRosiers C, Frost S, . Extracranial stereotactic radioablation: Results of a phase I study in medically inoperable stage I non-small cell lung cancer. Chest. 2003; 124:1946–55.
   PubMed Web of Science ®Google Scholar
• Hoyer M, Roed H, Hansen AT, Ohlhuis L, Petersen J, Nellemann H, . Prospective study on stereotactic radiotherapy of limited-stage non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2006; 66:s128–s135.
   Google Scholar
• Onishi H, Araki T, Shirato H, Nagata Y, Hiraoka M, Gomi K, . Stereotactic hypofractionated high-dose irradiation for stage I nonsmall cell lung carcinoma: Clinical outcomes in 245 subjects in a Japanese multiinstitutional study. Cancer. 2004; 101:1623–31.
   PubMed Web of Science ®Google Scholar
• Uematsu M, Shioda A, Suda A, Fukui T, Ozeki Y, Hama Y, . Computed tomography-guided frameless stereotactic radiotherapy for stage I non-small-cell cancer: A 5-year experience. Int J Radiat Oncol Biol Phys. 2001; 51:666–70.
   PubMed Web of Science ®Google Scholar
• Fukumoto S, Shirato H, Shimizu S, Ogura S, Onimaru R, Kitamura K, . Small-volume image-guided radiotherapy using hypofractionated, coplanar, and noncoplanar multiple fields for patients with inoperable stage I nonsmall cell lung carcinomas. Cancer. 2002; 95:1546–53.
   PubMed Web of Science ®Google Scholar
• Onimaru R, Shirato H, Shimizu S, Kitamura K, Xu B, Fukumoto S, . Tolerance of organs at risk in small-volume, hypofractionated, image-guided radiotherapy for primary and metastatic lung cancers. Int J Radiat Oncol Biol Phys. 2003; 56:126–35.
   PubMed Web of Science ®Google Scholar
• Bral S, Van Parijs H, Soete G, Linthout N, Van Moorter L, Verellen D, . A feasibility study of image-guided hypofractionated conformal arc therapy for inoperable patients with localized non-small cell lung cancer. Radiother Oncol. 2007; 84:252–6.
   PubMedGoogle Scholar
• Wulf J, Baier K, Mueller G, Flentje MP. Dose-response in stereotactic irradiation of lung tumors. Radiother Oncol. 2005; 77:83–7.
   PubMed Web of Science ®Google Scholar
• Timmerman R, Galvin J, Michalski J, Straube W, Ibbott G, Martin E, . Accreditation and quality assurance for Radiation Therapy Oncology Group: Multicenter clinical trials using Stereotactic Body Radiation Therapy in lung cancer. Acta Oncol. 2006; 45:779–86.
   PubMed Web of Science ®Google Scholar
• Nyman J, Johansson KA, Hulten U. Stereotactic hypofractionated radiotherapy for stage I non-small cell lung cancer-mature results for medically inoperable patients. Lung Cancer. 2006; 51:97–103.
   PubMed Web of Science ®Google Scholar
• Uematsu M, Shioda A, Tahara K, Fukui T, Yamamoto F, Tsumatori G, . Focal, high dose, and fractionated modified stereotactic radiation therapy for lung carcinoma patients: A preliminary experience. Cancer. 1998; 82:1062–70.
   PubMed Web of Science ®Google Scholar
• Bo X, Shirato H, Shimizu S, Arimoto T, Kagei K, Kitahara T, . Dose-volume analysis of stereotactic irradiation for lung tumors. J Radiosurg. 1999; 2:239–45.
   Google Scholar
• Takayama K, Nagata Y, Negoro Y, Mizowaki T, Sakamoto T, Sakamoto M, . Treatment planning of stereotactic radiotherapy for solitary lung tumor. Int J Radiat Oncol Biol Phys. 2005; 61:1565–71.
   PubMedGoogle Scholar
• Liu R, Buatti JM, Howes TL, Dill J, Modrick JM, Meeks SL. Optimal number of beams for stereotactic body radiotherapy of lung and liver lesions. Int J Radiat Oncol Biol Phys. 2006; 66:906–12.
   PubMedGoogle Scholar